Literature DB >> 8430451

White cell-reduced red cells prepared by filtration: a critical evaluation of current filters and methods for counting residual white cells.

P Rebulla1, L Porretti, F Bertolini, F Marangoni, D Prati, C Smacchia, M Pappalettera, A Parravicini, G Sirchia.   

Abstract

White cell (WBC) reduction, red cell (RBC) recovery, and filtration time were determined in 1-day-old standard and buffy coat-depleted RBCs filtered in the laboratory through six commercial filters for WBC reduction. Residual WBCs were counted with a Bürker chamber (BC), with a Nageotte chamber (NC), and by flow cytometry (FC). Results show that BC counts were 0 in several cases in which WBCs were detected with NC and FC, which indicated that the traditional BC method is too insensitive in use with currently available filters. Calibration curves performed by FC and with NC with samples containing known concentrations of WBCs from 1000 to 1 per microL showed that both FC and NC detected, on average, 67 percent of WBCs present in the samples (efficiency). However, the efficiency of FC showed small variability (61-70%) at different WBC levels, whereas the variability with NC was large (39-91%). This greater variability prevented the correction of NC counts by using a single factor and indicated difficulty in NC standardization. Therefore, because our main aim was to compare different filters rather than to define absolute levels of WBC contamination, uncorrected FC and NC counts were chosen to be reported. True WBC counts per unit should not exceed values that can be obtained by dividing uncorrected counts by the lowest efficiencies (61% for FC and 39% for NC). Uncorrected NC and FC counts were below 2 x 10(6) per unit in all units processed through three of the filters and below 5 x 10(6) per unit in all units processed through the other three.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8430451     DOI: 10.1046/j.1537-2995.1993.33293158044.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  DNA enzyme immunoassay of the PCR-amplified HLA-DQ alpha gene for estimating residual leukocytes in filtered blood.

Authors:  D Prati; B D Rawal; C Dang; C Capelli; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

2.  Leucodepletion and Blood Products.

Authors:  Harsh Kumar; P K Gupta; D K Mishra; R S Sarkar; M Jaiprakash
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Hemorrhage and subsequent allogenic red blood cell transfusion are associated with characteristic monocyte messenger RNA expression patterns in patients after multiple injury-a genome wide view.

Authors:  Viktoria Bogner; Henry V Baker; Karl-Georg Kanz; L L Moldawer; Wolf Mutschler; Peter Biberthaler
Journal:  J Trauma       Date:  2009-10

4.  Very early posttraumatic serum alterations are significantly associated to initial massive RBC substitution, injury severity, multiple organ failure and adverse clinical outcome in multiple injured patients.

Authors:  V Bogner; L Keil; K-G Kanz; C Kirchhoff; B A Leidel; W Mutschler; P Biberthaler
Journal:  Eur J Med Res       Date:  2009-07-22       Impact factor: 2.175

5.  Evaluation of riboflavin photochemical treatment for inactivation of HCT116 tumor cells mixed in simulative intraoperative salvage blood.

Authors:  Yang Yu; Lu Yang; Chunyu He; Shengfei Tai; Chunya Ma; Tianxin Yang; Deqing Wang
Journal:  Transfusion       Date:  2019-09-30       Impact factor: 3.157

6.  Comparison of Flow Cytometric Methods for the Enumeration of Residual Leucocytes in Leucoreduced Blood Products: A Multicenter Study.

Authors:  Yang Zeng; Michelle Dabay; Virginia George; Shalini Seetharaman; Monika de Arruda Indig; Sharon Graminske; Nicole Kimpel; Anna Schmidt; Amanda Boerner; Sarai Paradiso; Tatyana Delman; Yunyao Li; Viktoriya Litvak; Farzad Oreizy; Angela Chen; Maryam Saleminik; Fred Mosqueda; Anna Lin; Kevin Judge
Journal:  Cytometry A       Date:  2018-01-18       Impact factor: 4.355

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.